Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Savannah Chrisley When Savannah Chrisley first tried weight loss drugs, she stopped because she didn't like the way it manipulated her appetite
Rinschen MM, Ivanisevic J, Giera M, Siuzdak G
Novo Nordisk and the Next Wave of Weight Loss Drugs The Two-Company Market: Q1 2026 Head to Head Key Numbers Total Revenue: $19.8B (+56% YoY) Adjusted EPS: $8.55 (+156%) Mounjaro: $8.66B (+100%+ YoY) Zepbound: $4.16B (+80% YoY) US Market Share: 60.1% 2026 Guide: $82-85B (raised $2B) Total Revenue: $10.8B (beat estimates) Adjusted EPS: $1.03 (beat) Wegovy: DKK 18.2B (+12% YoY) Wegovy Pill: $354M (doubled estimates) US Market Share: 39.4% 2026 Guide: Adjusted sales decline 4-12% at CER The GLP-1 market in 2026 is a two-company duopoly with a widening gap
Cellular Repair and Muscle Recovery If the goal is to pack on dense muscle mass, repair a severely torn ligament, or put on healthy body weight, GHRP-6 steps into the spotlight
Peripheral nerve development and the pathogenesis of peripheral neuropathy: the sorting point
US$ 26.71
US$ 23.23
US$ 20.60
US$ 22.95
US$ 23.09
